Anest. intenziv. Med. 2017;28(4):248-254

Atrial fibrillation in critically ill patientsIntesive Care Medicine - Review Article

M. Harazim1,*, T. Karvunidis1,2, J. Raděj1,2, J. Horák1,2, I. Novák1, M. Matějovič1,2
1 I. interní klinika, Fakultní nemocnice Plzeň, Lékařská fakulta v Plzni, Univerzita Karlova
2 Biomedicínské centrum, Lékařská fakulta v Plzni, Univerzita Karlova

Arrhythmias are a common problem in the critically ill and they can have significant effects on patient outcome. Their management requires a structured approach, rapid diagnosis and correct treatment. We present a framework for the appropriate management of the most frequently encountered tachyarrhythmia in critical care.

Keywords: tachyarrhythmias; atrial fibrillation; critical care

Received: October 20, 2016; Accepted: April 12, 2017; Published: August 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Harazim M, Karvunidis T, Raděj J, Horák J, Novák I, Matějovič M. Atrial fibrillation in critically ill patients. Anest. intenziv. Med. 2017;28(4):248-254.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Reinelt P, Karth G, Geppert A, Heinz G. Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive care medicine. 2011;27:1466-1473. Go to original source... Go to PubMed...
    2. Knotzer H, lviayr A, Ulmer H, et al. Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. J Intensive Care Med. 2000;26:908-914. Go to original source... Go to PubMed...
    3. Feinberg W, Blackshear J, Laupacis A, Kronmal R, Hart R. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469-473. Go to original source...
    4. Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, Bögelein D, Stahl W. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Critical Care. 2010;14.3:1. Go to original source... Go to PubMed...
    5. Moss TJ, Ruminski C, Lake DE, Calland JF, Enfield KB, Moorman JR. The impact of incident atrial fibrillation in the intensive care unit. Journal of the American College of Cardiology. 2016;67.13:2358. Go to original source... Go to PubMed...
    6. Chen AY, Sokol SS, Kress JP, Lat I. New-onset atrial fibrillation is an independent predictor of mortality in medical intensive care unit patients. Ann Pharmacother. 2015;49:523-527. Go to original source... Go to PubMed...
    7. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56:539-549. Go to original source... Go to PubMed...
    8. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;226:501-511. Go to original source... Go to PubMed...
    9. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European heart journal. 2010, 31.19:2369-429.
    10. Mayr A, Ritsch N, Knotzer H, Dünser M, Schobersberger W, Ulmer H, et al. Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients. Crit Care Med. 2003;31:401-405. Go to original source... Go to PubMed...
    11. Ganga HV, Noyes A, White CM, et al. Magnesium adjunctive therapy in atrial arrhythmias. Pacing Clin Electrophysiol. 2013;36:1308-1318. Go to original source... Go to PubMed...
    12. Opolski G, Stanislawska J, Górecki A, et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clinical cardiology. 1997;20:337-340. Go to original source... Go to PubMed...
    13. Sticherling C, Behrens S, Kamke W, et al. Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion. Europace. 2005;7:546-553. Go to original source... Go to PubMed...
    14. Myerburg RJ, Castellanos A. Electrode positioning for cardioversion of atrial fibrillation. The Lancet. 2002;360:1263-1264. Go to original source... Go to PubMed...
    15. Kirchhof P., et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. The Lancet. 2002;360:1275-1279. Go to original source... Go to PubMed...
    16. Walsh J., et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions. Eur Heart J. 2005;26:1298-1302. Go to original source... Go to PubMed...
    17. Olshansky B, Heller EN, Mitchell LB., et al. Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?: Results From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Journal of the American College of Cardiology. 2005;45:2026-2033. Go to original source... Go to PubMed...
    18. Oral H, Ozaydin M., et al. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion. Journal of cardiovascular electrophysiology. 2003;14:182-185. Go to original source...
    19. Kanji S, Williamson DR., et al. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012; 27:326.e1-8. Go to original source... Go to PubMed...
    20. Gillinov AM, Bagiella E, Moskowitz AJ., et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016,374:1911-1921. Go to original source... Go to PubMed...
    21. Williams V. A classification of antiarrhythmic actions reassessed after a decade of new drugs. The Journal of Clinical Pharmacology. 1984;24:129-147. Go to original source... Go to PubMed...
    22. Naccarelli GV, Wolbrette DL, Khan M., et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. The American journal of cardiology. 2003;91:15-26. Go to original source... Go to PubMed...
    23. Cardiac Investigators, et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412. Go to original source... Go to PubMed...
    24. Wiest DB, Haney JS. Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clinical pharmacokinetics. 2012;51:347-356. Go to original source... Go to PubMed...
    25. Vietti-Ramus G, Veglio F., et al. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. International journal of cardiology. 1992;35:77-85. Go to original source... Go to PubMed...
    26. Amiodarone trials meta-analysis investigators, et al. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. The Lancet. 1997;350(9089):1417-1424. Go to PubMed...
    27. Goldman S, Probst P., et al. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. The American journal of cardiology. 1975;35:651-655. Go to original source...
    28. Trappe HJ. Vorhofflimmern - Gesichertes und Neues. Dtsch Arztebl Int. 2012;109:1-7. Go to PubMed...
    29. Saran T, Perkins GD, Javed MA, Annam V, Leong L, Gao F., et al. Does the prophylactic administration of magnesium sulphate to patients undergoing thoracotomy prevent postoperative supraventricular arrhythmias? A randomized controlled trial. Br J Anaesth. 2011;106:785-791. Go to original source... Go to PubMed...
    30. Moran JL, Gallagher J, Peake SL, Cunningham DN., et al. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med. 1995;23:1816-1824. Go to original source... Go to PubMed...
    31. Krijthe BP, Heeringa J, Kors JA, et al. Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol. 2013;168:5411-5415. Go to original source... Go to PubMed...
    32. Khan AM, Lubitz SA, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013;127:33-38. Go to original source... Go to PubMed...
    33. Lip YH, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest Journal. 2010;137:263-272. Go to original source... Go to PubMed...
    34. Pisters R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest Journal. 2010;138: 1093-1100. Go to original source... Go to PubMed...
    35. Tracy C, Boushahri A. Managing arrhythmias in the intensive care unit. Critical care clinics. 2014;30:365-390. Go to original source... Go to PubMed...
    36. Walkey AJ, et al. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306:2248-2254. Go to original source... Go to PubMed...
    37. Walkey AJ, et al. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest. 2014;146:1187-1195. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.